Apex Biotechnology Corp (1733) — Free Cash Flow Generation Index
Apex Biotechnology Corp (1733) has a Free Cash Flow Generation Index of 0.43x as of September 2025. Free cash flow of NT$2.22 Million represents 0% of operating cash flow (NT$5.19 Million). See working capital position of Apex Biotechnology Corp to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apex Biotechnology Corp Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for Apex Biotechnology Corp across 23 annual periods. Explore cash flow to debt ratio of Apex Biotechnology Corp to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Apex Biotechnology Corp (2002–2024)
Year-by-year Free Cash Flow Generation Index for Apex Biotechnology Corp. For the full company profile including market capitalisation, see Apex Biotechnology Corp (1733) market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$299.04 Million | NT$328.67 Million | NT$29.63 Million | ▲ +2.0% |
| 2023 | 0.89x | NT$205.41 Million | NT$230.39 Million | NT$24.98 Million | ▲ +274.7% |
| 2022 | -0.51x | NT$-13.58 Million | NT$26.62 Million | NT$40.20 Million | ▼ -159.7% |
| 2021 | 0.85x | NT$153.67 Million | NT$179.87 Million | NT$26.20 Million | ▲ +3.2% |
| 2020 | 0.83x | NT$232.28 Million | NT$280.60 Million | NT$48.32 Million | ▼ -5.7% |
| 2019 | 0.88x | NT$405.94 Million | NT$462.52 Million | NT$56.58 Million | ▲ +867.9% |
| 2018 | -0.11x | NT$-7.72 Million | NT$67.57 Million | NT$75.29 Million | ▼ -118.4% |
| 2017 | 0.62x | NT$44.07 Million | NT$70.83 Million | NT$26.76 Million | ▼ -28.6% |
| 2016 | 0.87x | NT$259.60 Million | NT$298.06 Million | NT$38.45 Million | ▼ -7.7% |
| 2015 | 0.94x | NT$445.49 Million | NT$472.15 Million | NT$26.66 Million | ▲ +24.9% |
| 2014 | 0.76x | NT$202.19 Million | NT$267.60 Million | NT$65.41 Million | ▲ +54.5% |
| 2013 | 0.49x | NT$237.08 Million | NT$484.77 Million | NT$247.69 Million | ▲ +162.5% |
| 2012 | 0.19x | NT$94.96 Million | NT$509.67 Million | NT$414.70 Million | ▼ -74.4% |
| 2011 | 0.73x | NT$198.82 Million | NT$273.45 Million | NT$74.63 Million | ▲ +11.2% |
| 2010 | 0.65x | NT$304.53 Million | NT$465.59 Million | NT$161.05 Million | ▼ -19.5% |
| 2009 | 0.81x | NT$317.95 Million | NT$391.29 Million | NT$73.34 Million | ▼ -43.3% |
| 2008 | 1.43x | NT$429.70 Million | NT$299.96 Million | NT$129.74 Million | ▲ +24.6% |
| 2007 | 1.15x | NT$419.34 Million | NT$364.62 Million | NT$54.71 Million | ▲ +3.1% |
| 2006 | 1.12x | NT$405.70 Million | NT$363.71 Million | NT$41.99 Million | ▼ -19.4% |
| 2005 | 1.38x | NT$293.44 Million | NT$212.14 Million | NT$81.30 Million | ▼ -35.6% |
| 2004 | 2.15x | NT$469.70 Million | NT$218.54 Million | NT$251.16 Million | ▲ +81.2% |
| 2003 | 1.19x | NT$358.46 Million | NT$302.25 Million | NT$56.21 Million | ▼ -33.0% |
| 2002 | 1.77x | NT$140.62 Million | NT$79.49 Million | NT$61.13 Million | — |